Genghis Lloyd-Harris - Profile and Investment Details

Investor Profile

Genghis Lloyd-Harris is a Venture Capital, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin, CRISPR Therapeutics, Attenua, Broncus Technologies, Jasper TherapeuticsSynosia Therapeutics, X4 Pharmaceuticals, Lean Life Science, Kspine, Zogenix, PrimeraDx (Primera Biosystems), Scorpion Therapeutics, Avila Therapeutics, Personalis, MD On-Line, GenSight Biologics, Dicerna Pharmaceuticals, Verona Pharma, Credit Suisse First Boston (now UBS), Micromet, Proteon Therapeutics, Prosensa, Stanmore Implants Worldwide, GTx, Median Technologies, Valeritas, Soleno Therapeutics, Wilson Therapeutics, Chroma Therapeutics, Avillion, Hydra Biosciences, Algeta, Sientra, Intellikine, Chiasma, Gynesonics, Reneo Pharmaceuticals, Vera Therapeutics, Portola Pharmaceuticals, Nouscom, Vaxcyte, Lombard Medical plc, Labcyte, Pathwork Diagnostics, Senseonics, Novexel, Clovis Oncology, Atsena Therapeutics, Cytos, VirionHealth, Phathom Pharmaceuticals, Fovea Pharmaceuticals, Venatorx Pharmaceuticals, IS Pharma, Cancer Research Horizons, Effector Therapeutics, Sonitus Medical, Paratek Pharmaceuticals, Q32 Bio, Abingworth, GammaDelta Therapeutics, Tizona Therapeutics, Oxagen, SFJ Pharmaceuticals, Avedro, IFM Therapeutics, Virion Biotherapeutics, Realm Therapeutics, Pixium Vision, . Over time, Genghis Lloyd-Harris has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Genghis Lloyd-Harris is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Health Diagnostics, UK-based Startups, Higher Education, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Genghis Lloyd-Harris, as their portfolio suggests a familiarity and interest in this area.

Understanding Genghis Lloyd-Harris’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.